NWM
CHRS icon

Northwest Wealth Management’s Coherus Oncology CHRS Stock Holding History

Northwest Wealth Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,700
Closed -$23K – 165
2019
Q1 		$23K Hold
1,700
– – 0.02% 285
2018
Q4 		$15K Buy
+1,700
New +$19.7K 0.01% 292

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Northwest Wealth Management's CHRS Position: Q2 2019 in Review

Northwest Wealth Management sold out of Coherus Oncology (CHRS) in Q2 2019, closing a stake of 1,700 shares — an estimated $23K sold.

Northwest Wealth Management first reported a position in CHRS in Q4 2018 and held it in 2 quarters. The position peaked at $23K in Q1 2019. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2019.

  • Northwest Wealth Management reported no remaining Coherus Oncology position as of Q2 2019 after selling out during the quarter.
  • Northwest Wealth Management sold 1,700 Coherus Oncology shares in Q2 2019, an estimated $23K.
  • Northwest Wealth Management first reported a position in Coherus Oncology in Q4 2018 and held it in 2 quarters.
  • Northwest Wealth Management's Coherus Oncology position peaked at $23K in Q1 2019.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2019.

Based on Northwest Wealth Management's 13F filing for Q2 2019, filed 23 Jul 2019.